Abstract
vasculitis predominantly affecting small to medium vessels" . However, these criteria (1) were not originally designed as diagnostic tools and diagnostic criteria still lack at the moment. The ongoing Diagnostic and Classification Criteria in Vasculitis (DCVAS) study has already settled the premises to develop and validate diagnostic criteria for systemic vasculitides . (2) In this report, we present a case of ANCAnegative EGPA that required transbronchial biopsy (TBB) for histopathological proof. We will discuss the diagnostic approach, emphasizing the spectrum of clinical features and paraclinical findings that could assist the diagnosis. 
Discussion
Our patient had an eosinophilic non-allergic asthma phenotype as proven by eosinophilia on BAL fluid cytology and negative allergy testing . Apart from BAL, airway tissue (3) biopsy and induced sputum identifying high eosinophil count are usually used to diagnose the eosinophilic asthma . As these (3) examinations are not always accessible, blood eosinophilia has been assigned as a predictive marker for sputum eosinophil count although it is an inconsistent finding in asthmatic patients and does not always correlate with sputum eosinophilia . ( 3 ) Nevertheless, it does correlate well with the Clinical cases 67 severity of asthma (recurrent exacerbations, high disease burden) . Regardless of the (3) (4) (5) facts mentioned above, the significant blood eosinophilia (>10%) drew our attention because it occurs rarely in asthmatic p a t i e n t s . P e r s i s t e n t b i o l o g i c a l ( 6 ) inflammatory syndrome and multiple organ (lung, kidney) involvement were highly suggestive of a systemic inflammatory Our patient fulfilled five of the ACR 1990
Criteria for the classification of Churg-S t r a u s s s y n d ro m e , n a m e l y a s t h m a , eosinophilia, non-fixed pulmonary infiltrates, p a r a n a s a l s i n u s a b n o r m a l i t i e s a n d extravascular eosinophils. As mentioned above, these criteria were designed for classification (not diagnostic) purposes, implying that a biopsy-proven vasculitis can be classified as EGPA with a sensitivity of 85% and a specificity of 99.7% if at least four of these criteria are met . We managed to (6) obtain a biopsy specimen via a minimally invasive procedure (TBB) that was able to identify two pathognomonic features of EGPA.
Although it is commonly stated that surgical lung biopsy provides conclusive pathologic evidence, TBB has showed some promising results in a small study conducted by Schnabel et al in 1997: 4 out of 6 EGPA p a t i e n t s w i t h n a s a l / p a r a n a s a l histopathological confirmation had a positive TBB . Subsequently, only few cases of EGPA (7) diagnosed by TBB have been reported , (8) (9) (10) indicating a low yield of this procedure.
However, given its high profile safety, it should be considered an alternative diagnostic technique in EGPA . (10) We n o t i c e d a n A N C A-n e g a t i v e E G PA phenotype that occurs in 40%-70% of cases and is usually linked to the eosinophilic phase (i.e. organ damage mediated by eosinophilic infiltration . However, renal involvement (1) and histopathological evidence of vasculitis strongly indicated the emergence of the vasculitic phase.
Moreover, an ANCA-negative phenotype usually associates cardiomyopathy rather than glomerulonephritis, as opposed to our case . (11) These findings emphasize the fact that in Clinical cases
